The Impact of Peripheral Venous Disease In CTEPH

Forgot your password?

Select specialty

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

By PERT Consortium 2022 FEATURING Vladimir Lakhter

December 16, 2022

Rush University Medical Center

PERT Consortium 2021

S. Konstantinides

Arthroplasty Society in Asia

Arthroplasty Society in Asia

Mitral Foundation

R. Martin, A. Anyanwu

Arthroplasty Society in Asia

A. Tanavalee

Mount Sinai Advanced Heart Disease Symposium 2017

Cleveland Clinic Rheumatology

University of Colorado Department of Medicine

T. Bat, M. Carrier

S. Elias, C. Pena, C. Huff, R. Winokur, K. BROWN

National Jewish Health

James Douketis

Scripps Health

CHEST Annual Meeting Insights

B. Rivera-Lebron

T. Bat, M. Carrier

Pulmonary Embolism 2016

Keck School of Medicine of USC

Login

Login

Join VuMedi

The Impact of Peripheral Venous Disease In CTEPH

The Clinical PE Story: PEERLESS RCT Comparing FlowTriever to CDT

The Clinical PE Story: PEERLESS RCT Comparing FlowTriever to CDT

Related Videos

COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…

New European Guidelines on Pulmonary Embolism: What Has Changed and …

VTE Prophylaxis After THA for Asian Population: Pharmacological Prop…

VTE Prophylaxis After THA: Chinese Experience

CTEPH - Chronic Thromboembolic Pulmonary Hypertension Thoughts on Di…

VTE Prophylaxis After THA in the Asians: Messages from 2019 AP VTE C…

Pulmonary Hypertension: The Basic Essential Facts

How do I Recognize and Treat the VEXAS Syndrome?

Interstitial Lung Disease in Rheumatic Diseases

Cancer-Associated Thrombosis: Defining, Risk Assessment, and Prognos…

Acute DVT: When to and When Not to Intervene?

CardioPulmonary Exercise Test (CPET) Interpretation for Non-Experts

Prevention and Treatment of Cancer-Associated Thrombosis: What Are t…

Pulmonary Hypertension Due to Lung Disease / Chronic Pulmonary Embol…

CHEST 2024 Insights: (Mechanical) Support in RV Failure - Let's Keep…

Pulmonary Embolism: Where Are We in 2024?

Cancer-Associated Thrombosis: Anticoagulant Dose and Duration Consid…

PE - The Great Masquerader: A Disease of Many Faces: Cases Where I W…

Management of Acute Pulmonary Embolism: How Long Do You Treat?

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for …